Clinical Trials
2 trialsNCT06643221 2026-06-05
Allo-X
University of Arizona
Phase EARLY_PHASE1 Recruiting
NCT01888952 2017-02-27
Phase 0/1 Biomarker and Pharmacodynamic Study of Roflumilast in Patients With Advanced B-Cell Hematologic Malignancies (CTRC# 13-0013)
The University of Texas Health Science Center at San Antonio
Phase EARLY_PHASE1 Completed